SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jagsonpal Pharmaceuticals submits copy of Clause 20

16 Jun 2015 Evaluate

Jagsonpal Pharmaceuticals has submitted a copy of Clause 20 as per the Listing Agreement for period ended March 31, 2015.

The above information is a part of company’s filings submitted to BSE.

Jagsonpal Pharma Share Price

222.90 10.55 (4.97%)
22-Jun-2026 14:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1860.50
Dr. Reddys Lab 1295.40
Cipla 1415.00
Zydus Lifesciences 1075.00
Lupin 2341.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: